Infant Bacterial Therapeutics gets Orphan Drug Designation in Europe
Infant Bacterial Therapeutics (IBT), subsidiary of BioGaia, is in the early stages of developing a drug to prevent necrotizing enterocolitis (NEC) which is a rare and fatal disease that affects premature infants. IBT has now obtained the Orphan Drug Designation for the prevention of NEC in Europe, which complements the corresponding designation in the US from FDA, granted in August 2013.
“We are pleased that the European Commission have granted the Orphan Drug Designation. We are confident that our subsidiary IBT can significantly contribute in the care of premature infants in the future”, says Peter Rothschild, CEO, BioGaia.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Johns Hopkins University School of Medicine Presentation Highlights SELDI Technology for Proteomic Analysis in Kidney Transplant - Ciphergen's ProteinChip® System enables discovery of multiple biomarkers and predictive assay for kidney transplant rejection
Pall Opens New Life Sciences Centre of Excellence in Shanghai

DNA nanotubes build a bridge between 2 molecular posts

Protein could help in early detection of malignant Hodgkin's lymphoma

Hypertrust Patient Data Care GmbH - München, Germany
Perceptronix Announces Completion of ClearVu Elite Clinical Study

Test detects signs of Lyme disease near time of infection
Unravelled potato genome paves the way for new varieties

Nursery of the Blood: How Stem Cells Calm the Body’s Immune Response - The researchers uncovered an unexpected finding
Gregor Mendel Institute of Molecular Plant Biology GmbH - Wien, Austria
